eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
3/2023
vol. 10
 
Share:
Share:
abstract:
Review paper

Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?

Przemysław Seweryn
1
,
Andrzej Emeryk
2
,
Maciej Kupczyk
3
,
Radosław Gawlik
4
,
Tomasz Dębowski
1
,
Grzegorz Sztaba
1
,
Rafał Pawliczak
5

  1. Chiesi Poland Sp. z o.o.
  2. Zakład Pediatrii i Pielęgniarstwa Pediatrycznego, Katedra Zintegrowanej Opieki Pielęgniarskiej, Wydział Nauk o Zdrowiu Collegium Academicum, Uniwersytet Medyczny w Lublinie, Lublin, Polska
  3. Klinika Chorób Wewnętrznych, Astmy i Alergii, II Katedra Chorób Wewnętrznych, Wydział Lekarski, Uniwersytet Medyczny w Łodzi, Łódź, Polska
  4. Katedra i Klinika Chorób Wewnętrznych, Alergologii i Immunologii Klinicznej, Wydziału Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach, Polska
  5. Zakład Immunopatologii, Wydział Lekarski, Uniwersytet Medyczny w Łodzi, Łódź, Polska
Alergologia Polska – Polish Journal of Allergology 2023; 10, 3: 198–201
Online publish date: 2023/09/30
View full text Get citation
 
PlumX metrics:
The out-of-pocket cost of asthma and chronic obturative pulmonary disease therapy might be a limiting factor of the therapy for many patients in Poland. Does the out-of-pocket copayment influence the therapy choice, specifically where the treatment is reimbursed? Do the therapy cost paid by the patient have any influence on treatment compliance? Will the introduction of the generic medication identical to the innovative drug, but available at lower cost change the therapy adherence? In this review we are trying to answer the aforementioned questions.
keywords:

asthma, treatment, formoterol, beclomethasone



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.